Vivos Therapeutics VVOS
NASDAQ VVOS
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vivos Therapeutics (VVOS) Asset Writedowns and Impairment (2023)

Updated

Vivos Therapeutics' Asset Writedowns and Impairment was $151,000 in Q3 2023.

Analysis

Vivos Therapeutics (VVOS) Asset Writedowns and Impairment (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Vivos Therapeutics 2.18 Mn -7.03 Mn 2.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 151,000.00
API Access

Vivos Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VVOS&period=max&api_key=YOUR_API_KEY